TAG:
laboratory industry
Quest Wants It Both Ways with Payer Contracts
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: Once again, public laboratory companies are pursuing short-term strategies that promise competitive advantage to themselves. But these strategies also carry long term risks that could burden the entire laboratory industry. Contradictions in the current cycle of competition fo…
ACLA Prepares to Tackle Tough Lab Industry Issues
By Robert Michel | From the Volume XIV No. 7 – May 14, 2007 Issue
CEO SUMMARY: At its annual meeting last month, the American Clinical Laboratory Association (ACLA) rolled out a new campaign to educate Congress, government and private payers, and the American public about the value of laboratory testing. Called “Results for Life,” the campaign is a …
Why Labs Will Increase their Use of Middleware and Informatics
By Robert Michel | From the Volume XIV No. 6 – April 23, 2007 Issue
“Across the globe, laboratories face similar and significant challenges in how they use information technology and middleware to solve problems.” —Jacques Baudin, Executive Vice President, Technidata America Medical Software CEO SUMMARY: Midd…
FDA Sends Warning Letter to Abbott Laboratories
By Robert Michel | From the Volume XIV No. 6 – April 23, 2007 Issue
CEO SUMMARY: On March 13, 2007, the Food and Drug Administration sent a warning letter to Abbott Laboratories’ Chairman and CEO, Miles D. White. The letter identified nine quality system violations and requested a satisfactory response by August 15, 2007. The warning letter is based on …
Quest Bites: Will Pay $2 Billion for AmeriPath
By Robert Michel | From the Volume XIV No. 6 – April 23, 2007 Issue
CEO SUMMARY: From its inception in the mid-1990s as a pathology physician practice management (PPM) company, AmeriPath was a business that its investors created specifically to be sold. Now Quest Diagnostics Incorporated is stepping up to pay a princely ransom of $2 billion to make AmeriP…
Labs Can Be Misguided by Pull-Through Test Myth
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
CEO SUMMARY: For the first time in almost eight years, there are major disruptions to the status quo in managed care contracting for laboratory testing services. As was true in the 1990s, national lab companies are pursuing exclusive national contracts with the nation’s…
Implementation Date Passes on Medicare Competitive Bid Project
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
YESTERDAY, APRIL 1, WAS THE DAY that the Centers for Medicare & Medicaid (CMS) was scheduled to implement the first sites for the Medicare Clinical Laboratory Services Competitive Bidding Demonstration project. It was good news for the laboratory industry that the day passed with…
Pumping Up Performance of Lab Billing & Collections
By Robert Michel | From the Volume XIV No. 4 – March 12, 2007 Issue
CEO SUMMARY: Coding, billing, collections, and compliance continue to grow in complexity, making management of the lab’s revenue cycle ever more difficult. One by one, a number of the nation’s largest laboratories are taking steps to automate management of their revenue cycle by utili…
Aetna Says: LabCorp Is Out & Quest Diagnostics Is In
By Robert Michel | From the Volume XIV No. 4 – March 12, 2007 Issue
CEO SUMMARY: January 1, 2007 can be considered the start of a new epoch in managed care contracting for lab test services. News of Aetna’s decision to favor Quest Diagnostics Incorporated with a five-year contract as its only national laboratory provider shows the direction this new epo…
March 12, 2007 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIV No. 4 – March 12, 2007 Issue
It’s the first opportunity to see how a New York-area laboratory is doing at grabbing UnitedHealth business. Bio-Reference Laboratories, Inc. (BRLI) of Elmwood Park, New Jersey, announced earnings for its first quarter (ending on January 31) in its 2007 fiscal year…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized